Endpoints News
Former Akero team unveils new I&I company Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M Tue W Th F
14 July, 2026
Endpoints 11 - Reserve Your Spot
The most differentiated science stays out of public view. This September, the Endpoints newsroom reveals the 11 private companies worth watching, live at the State Room in Boston. See the list first, reserve your spot and save with the early bird rate.
SPOTLIGHT
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
ENDPOINTS NEWS
news
AstraZeneca to take rights to Dizal's lung cancer pill for $600M upfront
ENDPOINTS NEWS
Exclusive: Genetic medicine startup launches to speed programs that stalled at Editas, Biogen
ENDPOINTS NEWS
After $4.7B sale to Novo Nordisk, former Akero team announces new I&I company with China drug
ENDPOINTS NEWS
In latest deal, Innovent seeds Spero's future beyond GSK-owned antibiotic
ENDPOINTS NEWS
Endpoints webinars
Jul 30
1:00 pm ET
Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights
GUARDANT
Aug 19
1:00 pm ET
From pilots to production: AI across R&D, safety, regulatory, and clinical
IBM
Manufacturing Day 2026
A year into the tariff era, the biopharma industry has stopped bracing for impact — however manufacturing and supply chain leaders are still rewriting their plans on the fly. We’re bringing together the experts tracking what R&D logistics looks like today. Join us — find out what’s next.
in case you missed it
1.
Biopharma's 'extraordinary year' for M&A sets tone as earnings cycle begins
ENDPOINTS NEWS
2.
FDA finalizes guidance on psychedelics, plans broader hearing
ENDPOINTS NEWS
3.
Cayman court says Apple Tree general partner should lose control of venture fund 
ENDPOINTS NEWS
4.
News Briefing
Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial
ENDPOINTS NEWS
5.
FDA proposes to streamline registration of drugmakers' foreign and US factories
ENDPOINTS NEWS
6.
UK launches national dementia registry to speed up search for treatments
Financial Times
Reynald Castaneda
.

Don't forget that nominations for this year's Endpoints 11 will close tomorrow, July 15. Check out the details here.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.